A. B. Multi Pharma Private Limited

A. B. Multi Pharma Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U51397DL1999PTC099775 Incorporated 14 May 1999 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Revenue · FY 2025
₹23.78 Cr
▼ 6% YoY
Net profit · FY 2025
₹11.41 Lakh
Net margin 0.5%
EBITDA · FY 2025
₹11.41 Lakh
EBITDA margin 0.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹79,300
Issued & subscribed
Open charges
₹73.8 Lakh
Secured borrowings
Company age
27 yrs
Est. 1999
Directors on board
2
As per MCA filings

About A. B. Multi Pharma Private Limited

Data last updated:

A. B. Multi Pharma Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 May 1999 and has been in existence for over 27 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL1999PTC099775. Its GSTIN is 07AADCA5447P1Z9 (Delhi).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹79,300. It is led by directors Anvitaa Bajaj and Ashish Bajaj.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 13 Lsc Padam Nagar Sarai Rohilla, Delhi, India – 110007.

As per the financials filed for FY 2025, the company reported a revenue of ₹23.78 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹11.41 Lakh (net margin 0.5%) and EBITDA of ₹11.41 Lakh (EBITDA margin 0.5%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 2% over five years.

As per MCA filings, the company has open charges of ₹73.8 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51397DL1999PTC099775
Registration Number 099775
Incorporation Date 14 May 1999
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

A. B. Multi Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    A – 13 Lsc Padam Nagar Sarai Rohilla, Delhi, India – 110007
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of A. B. Multi Pharma Private Limited, buy the company report.

Comprehensive company report
A. B. Multi Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of A. B. Multi Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of A. B. Multi Pharma Private Limited, buy the company report.

Financials of A. B. Multi Pharma Private Limited

FY 2025 filings available

A. B. Multi Pharma Private Limited reported revenue of ₹23.78 Cr (down 6% YoY) for FY 2025.

Revenue · FY 2025
₹23.78 Cr ▼ 6%
Net profit · FY 2025
₹11.41 Lakh margin 0.5%
EBITDA · FY 2025
₹11.41 Lakh margin 0.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 2%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 4%
3 years · compounded
▼ 3%
5 years · compounded
▼ 2%

Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 6% fall in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹11.41 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹11.41 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.5%
Net Profit Margin0.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of A. B. Multi Pharma Private Limited, buy the company report.

Board of directors of A. B. Multi Pharma Private Limited

A. B. Multi Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anvitaa BajajAdditional Director21 Jan 20215 Years 10 MonthsCurrent
Ashish BajajAdditional Director23 Jan 20215 Years 9 MonthsCurrent

Peer comparison

A. B. Multi Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Southern Surgicals Private Limited₹23.98 Cr (FY 2025)10.0%Bangalore, Karnataka, India
MG Worldwide Private Limited₹23.94 Cr (FY 2025)35.0%New Delhi, Delhi, India
Yolo Eximcare Private Limited₹23.93 Cr (FY 2025)98.0%P S Kotwali, Bihar, India
A. B. Multi Pharma Private Limitedthis company₹23.78 Cr (FY 2025)₹11.41 Lakh0.5%-6.0%Delhi, India
Harihar Medical Agencies Private Limited₹23.64 Cr (FY 2025)7.0%Ranchi, Jharkhand, India

To see the full peer comparison of A. B. Multi Pharma Private Limited, buy the company report.

Auditor

A. B. Multi Pharma Private Limited is audited by VIVEK VERMA & ASSOCIATES for the financial year 2016.

Auditor firmFinancial yearFirm registration number
VIVEK VERMA & ASSOCIATESFY 2016006601N

Shareholding

The shareholding of A. B. Multi Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of A. B. Multi Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹73.8 Lakh
Satisfied charges
None
Breakdown by lending institutions
Punjab National Bank₹0.74 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Mar 201310418966Punjab National Bank₹4.6 LakhOpen
18 Jun 200910169474Punjab National Bank₹6.55 LakhOpen
12 Oct 200710072111Punjab National Bank₹6.3 LakhOpen
02 Nov 200610022599Punjab National Bank₹50 LakhOpen
05 Oct 200610021825Punjab National Bank₹6.35 LakhOpen

To see the full charge records of A. B. Multi Pharma Private Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for A. B. Multi Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

A. B. Multi Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AADCA5447P1Z9DelhiActive01 Jul 2017

To see the full GST registrations and return filing status of A. B. Multi Pharma Private Limited, buy the company report.

Recent activity

A. B. Multi Pharma Private Limited has 6 board changes on record since 2012: 2 appointments and 4 cessations. The latest: Ashish Bajaj was appointed as Additional Director on 23 Jan 2021.

AGM
A. B. Multi Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
A. B. Multi Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Ashish Bajaj was appointed as Additional Director.
Ceased
Anmol Bajaj ceased to be Director.
Appointed
Anvitaa Bajaj was appointed as Additional Director.
Ceased
Ashish Bajaj ceased to be Director.
Ceased
Sudesh Bajaj ceased to be Additional Director.
Charges
A charge with Punjab National Bank amounted to Rs. 4.60 Lakh with Charge ID 10418966 was registered on 07 Mar 2013.
Ceased
Parkash Chander Bajaj ceased to be Director.
Charges
A charge with Punjab National Bank amounted to Rs. 6.55 Lakh with Charge ID 10169474 was registered on 18 Jun 2009.
Charges
A charge with Punjab National Bank of Rs. 50.00 Lakh registered on 02 Nov 2006 with Charge ID 10022599 was modified on 31 Mar 2008.
Charges
A charge with Punjab National Bank amounted to Rs. 6.30 Lakh with Charge ID 10072111 was registered on 12 Oct 2007.

3 earlier events are in the company report.

Frequently asked questions

A. B. Multi Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 May 1999 (27+ years old) and is registered under CIN U51397DL1999PTC099775.

A. B. Multi Pharma has 2 current directors:

The latest financial statements of A. B. Multi Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of A. B. Multi Pharma is 07AADCA5447P1Z9, registered in Delhi.

The CIN (Corporate Identification Number) of A. B. Multi Pharma is U51397DL1999PTC099775. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

A. B. Multi Pharma was incorporated on 14 May 1999, making it 27+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of A. B. Multi Pharma by revenue are Southern Surgicals Private Limited, MG Worldwide Private Limited, Yolo Eximcare Private Limited, Harihar Medical Agencies Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Ashish Bajaj was appointed as Additional Director on 23 Jan 2021. Anmol Bajaj ceased to be Director on 21 Jan 2021. Anvitaa Bajaj was appointed as Additional Director on 21 Jan 2021. A. B. Multi Pharma has 6 board changes on record in total.

The registered office of A. B. Multi Pharma is at A – 13 Lsc Padam Nagar Sarai Rohilla, Delhi, India – 110007.

A. B. Multi Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

A. B. Multi Pharma has open charges of ₹73.8 Lakh and no satisfied charges on record as per latest MCA filings.